QUB spin-out developing Angicyte cell therapy for vascular regeneration and chronic wounds.
| Date | Round | Amount |
|---|---|---|
| Aug 2022 | Funding round Belfast QUB spin-out VascVersa secured over £500k from Co-Fund NI, HBAN angels and QUBIS to develop its vascular cell therapy. | $650K |
| May 2021 | Seed Belfast medtech VascVersa, a QUB spin-out developing a cell therapy to repair damaged blood vessels, closed a six-figure seed round led by QUBIS, with Co-Fund NI and HBAN. | — |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.